Pap/HPV cotesting better for cervical cancer screening in over 30s
(HealthDay)—Liquid-based cytology (LBC) and human papillomavirus (HPV) cotesting enhances screening for cervical cancer (CxCa) and precancer among women aged 30 years and older, according to a study published online July ...
Jul 14, 2020
0
2